GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for FONDA - CABG

FONDA - CABG

Official Title

Fondaparinux to Prevent Thrombotic Complications & Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery.

Status

Completed

Overview

To demonstrate the feasibility of recruiting patients into this study and of performing CT angiograms to measure graft patency at 30 days. Our pilot study will provide key information about feasibility that will help us to design and perform a large definitive study in the future.

Study Design

Randomized, treatment, open label, active control, parallel group design.

Primary Endpoint

All primary and secondary endpoints are adjudicated. Graft patency. Secondary Endpoint: Myocardial infarction, Stroke, Death, Bleeding events, Transfusion requirements, Re-operation.

Number of Patients

50

Number of Sites

1

Number of Countries

1

Study Period

2008–2009

Program Manager

Not Applicable

Research Coordinator

Susan Chrolavicius